Abstract
Simple, sensitive, and reproducible off-line solid-phase microextraction and liquid chromatography (SPME/LC) methods are described for the determination of seven anticonvulsants and tricyclic antidepressants in human plasma. Factorial design and simplex methodology were applied in the optimization of the SPME procedure for tricyclic antidepressants analyses. Important factors in the SPME efficiency are discussed, such as the fiber coatings (both lab-made and commercial), extraction time, pH, ionic strength, influence of plasma proteins, and desorption conditions. The development of the lab-made fiber coatings, namely, octadecylsilane, aminosilane, and polyurethane, are further described and applied to anticonvulsants analyses. The investigated plasmatic range for the evaluated anticonvulsants, using CW-TPR fiber, were the following: phenylethylmalonamide (3.00–40.0 μg mL−1), phenobarbital (5.00–40.0 μg mL−1), primidone (3.00–40.0 μg mL−1), carbamazepine and carbamazepine-epoxide (2.00–24.0 μg mL−1), phenytoin (2.00–40.0 μg mL−1), and lamotrigine (0.50–12.0 μg mL−1). The antidepressants’ linear plasmatic concentration ranged from 75.0 to 500 ng mL−1 for imipramine, amitriptyline, and desipramine, and from 50.0 to 500 ng mL−1 for nortriptyline, being in all cases, the limit of quantification represented by the lowest value. The precision (interassays) for all investigated drugs in plasma sample spiked with different concentrations of each analyte and submitted to the described procedures were lower than 15%. The off-line SPME/LC methodologies developed allow anticonvulsants and antidepressants analyses from therapeutic to toxic levels for therapeutic drug monitoring.
Similar content being viewed by others
References
Muller MJ, Dragicevic A, Fric M, Gaertner I, Grasmader K, Hartter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C (2003) Pharmacopsychiatry 36:98–104
Le Bloc’h Y, Woggon B, Weissenrieder H, Brawand-Amey M, Spagnoli J, Eap CB, Baumann P (2003) Ther Drug Monit 25:600–608
Romeiro LAS, Fraga CAM, Barreiro EJ (2003) Quim Nova 26:347–358
Shorvon S, Stefan H (1997) Epilepsia 38:S45–S51
Frahnert C, Rao ML, Grasmäder K (2003) J Chromatogr B 794:35–47
Mandrioli R, Ghedini N, Albani F, Kenndler E, Raggi MA (2003) J Chromatogr B 783:253–263
Cantú MD, Hillebrand S, Queiroz MEC, Lanças FM, Carrilho E (2004) J Chromatogr B 799:127–132
Queiroz MEC, Carrilho E, Carvalho D, Lanças FM (2001) Chromatographia 53:485–489
Kollroser M, Schober C (2002) Ther Drug Monit 24:537–544
Jinno K, Kawazoe M, Hayashida M (2000) Chromatographia 52:309–313
Saito Y, Kawazoe M, Hayashida M, Jinno K (2000) Analyst 125:807–809
Pawliszyn J (ed) (1999) Applications of solid phase microextraction. Royal Society of Chemistry, Cambridge, pp 1–72
Queiroz MEC, Silva SM, Carvalho D, Lanças FM (2001) J Environ Sci Health Part B 36:517–527
Alpendurada MF (2000) J Chromatogr A 889:3–14
Krutz LJ, Senseman SA, Saumbato AS (2003) J Chromatogr A 999:103–121
Ulrich S (2000) J Chromatogr A 902:167–194
Furton KG, Wang J, Hsu YL, Walton J, Almirall JR (2000) J Chromatogr Sci 38:297–306
Theodoridis G, Koster EHM, Jong GJ (2000) J Chromatogr B 745:49–82
Snow NH (2000) J Chromatogr A 885:445–455
Abdel-Rehim M, Hassan Z, Blomberg L, Hassan M (2003) Ther Drug Monit 25:400–406
Frison G, Tedeschi L, Maietti S, Ferrara SD (2000) Rapid Commun Mass Spectrom 14:2401–2407
Zambonin CG, Aresta A (2002) J Pharm Biomed Anal 28:895–900
Walles M, Mullett WM, Pawliszyn J (2004) J Chromatogr A 1025:85–92
Kumazawa T, Seno H, K Watanabe-Suzuki, Hattori H, Ishii A, Sato K, Suzuki O (2000) J Mass Spectrom 35:1091–1099
Popp P, Bauer C, Moder M, Paschke A (2000) J Chromatogr A 897:153–159
Sarrion MN, Santos FJ, Galceran MT (2002) J Chromatogr A 947:155–165
Queiroz MEC, Silva SM, Carvalho D, Lanças FM (2002) J Sep Sci 25:91–95
Araujo PW, Brereton RG (1996) Trends Anal Chem 15:26–31
Barros-Neto B, Scarmínio IS, Bruns RE (1996) Planejamento e otimização de experimentos. Editora da Unicamp, Campinas
Walters F (1999) Anal Lett 32:193–293
Malmonge JA, Campoli CS, Malmonge LF, Kanda DHF, Mattoso LHC, Chierice GO (2001) Synthetic Metals 119:87–88
Queiroz MEC, Lanças FM (2004) LCGC North America 22:970–980
Queiroz MEC, Carvalho D, Lanças FM (2002) J Chromatogr Sci 40:219–223
Pawliszyn J (1997) Solid Phase Microextraction: theory and practice. Wiley, New York, pp 1–139
Miller JC, Miller JN (1993) Statistics for analytical chemistry. Ellis Horwood Prentice Hall, New York
Ulrich S, Martens J (1997) J Chromatogr B 696:217–234
Queiroz RHC, Lanchote VL, Bonato PS, Carvalho D (1995) Pharmaceutica Acta Helvetiae 70:181–186
Queiroz MEC, Carrilho E, Carvalho D, Lanças FM (2001) Chromatographia 53:485–489
Namera A, Yashiki M, Liu J, Hara K, Imamura T, Kojima T (2000) Forensic Sci Int 109:215–223
Acknowledgements
The authors acknowledge financial suport and fellowships from FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cantú, M.D., Toso, D.R., Lacerda, C.A. et al. Optimization of solid-phase microextraction procedures for the determination of tricyclic antidepressants and anticonvulsants in plasma samples by liquid chromatography. Anal Bioanal Chem 386, 256–263 (2006). https://doi.org/10.1007/s00216-006-0629-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-006-0629-5